Mineralys Therapeutics, Inc. Common Stock
MLYS
$26.89-8.54%
End of day · as of Sep 24, 2026, 9:01 AM ET
Mkt cap
$2.17B
EV/Sales
N/A
P/E ratio
N/A
Revenue (FY2025)
N/A
EPS (H1 2026)
$-3.00
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
0.56
Div yield
N/A
Sector
Healthcare
Mineralys Therapeutics, Inc. Common Stock (MLYS) is a biotechnology company listed on US.
Use this MLYS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full MLYS income, balance, and cash tables.
Mineralys Therapeutics, Inc. Common Stock (MLYS) is a biotechnology company in the Healthcare sector.
Latest cached Mineralys Therapeutics, Inc. Common Stock (MLYS) net income for FY2025 was -$154.7M. Statements: https://lician.com/financials/mlys
Mineralys Therapeutics, Inc. Common Stock (MLYS) market capitalization is $2.17B on the latest cached snapshot.
Mineralys Therapeutics, Inc. Common Stock (MLYS) cached previous close $29.40; day range $26.62 – $29.83; volume 1,478,025. Session quote: https://lician.com/quote/mlys
Mineralys Therapeutics, Inc. Common Stock (MLYS) latest cached earnings event is "MLYS earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached MLYS filing is 8-K · Oct 19, 2026. Filings: https://lician.com/sec/mlys